
Advancing Human and Animal Health Through OMM Research
In a groundbreaking initiative, the Humanimal Trust is funding a new cancer study focused on oronasal mucosal melanoma (OMM), a serious oral cancer affecting dogs and potentially enlightening treatments for humans. A £250,000 donation from the Humanimal Trust’s Cancer Discovery Fund is set to propel this innovative research led by a skilled team from the University of Edinburgh and NHS Lothian.
Causes and Impact of OMM
OMM is the most prevalent oral cancer found in canines, often with a grim prognosis—as dogs diagnosed with this condition typically survive less than a year. Major breeds like poodles, golden retrievers, and dachshunds are among those at greater risk. While OMM is relatively rare in humans, findings indicate striking similarities in its behavior and biology across species, which may provide key insights for creating more effective treatments.
Bridging Veterinary and Human Medicine
The Humanimal Trust emphasizes that cancer affects all species equally; approximately 1 in 4 dogs, 1 in 3 cats, and an alarming 1 in 2 humans will face a cancer diagnosis at some point. The collaborative nature of this study represents a significant step toward reciprocal advancements in veterinary and human oncology. Joe Bailey, CEO of the Humanimal Trust, emphasizes this as a pioneering strategy to ensure that advancements benefit both animals and humans simultaneously.
Potential for Transformative Treatments
Dr. Kelly Blacklock, among the team's leaders, previously identified commonalities between canine and human OMM—suggesting that therapies effective for dogs could also aid human patients. The study plans to explore these biases further with the aim of transforming current treatment protocols for OMM using a combination of surgery, radiotherapy, and potentially new immunotherapies. Dr. Blacklock's prior findings also highlight the importance of personalized treatment approaches.
Continuing the Legacy of Comparative Oncology
This work builds on previous research facilitated by the Kennel Club Charitable Trust. As the team embarks on this new phase of research, they hope to bridge disparities between canine and human health care systems, paving the way for innovative therapeutic solutions. This approach not only aims to improve prognosis for our pets but also to enrich the health prospects of human patients suffering from similar cancers.
Veterinary practices, particularly those aiming to enhance operational efficiency and client care, should stay informed on such advancements. By embracing and understanding the crossover of veterinary and human medical research, they can better position themselves to serve their communities.
Write A Comment